首页|基于Taqman荧光ARMS-PCR技术检测KRAS基因突变方法的建立

基于Taqman荧光ARMS-PCR技术检测KRAS基因突变方法的建立

扫码查看
一种新型的基于Taqman荧光的ARMS-PCR检测技术用于人石蜡包埋组织样本KRAS基因突变的技术已成功构建,该方法有望为临床用药提供参考依据.针对KRAS基因,研究人员设计了两种特异性引物以及探针,分别针对KRAS的常见突变位点序列和内参基因(GAPDH)的保守序列.随后,他们构建了 KRAS Taqman荧光ARMS-PCR检测体系以及测序体系.对200例结直肠癌(colorectal cancer,CRC)病人体组织样本进行石蜡包埋的检测,并与金标准sanger测序进行对比,以验证结果的统计分析,探讨KRAS基因突变在两种检测方法中的表现.结果显示,该方法能够准确检测石蜡包埋组织样本中的KRAS基因突变,该检测方法的准确度高达100%,与传统的Sanger测序结果完全一致.本研究基于Taqman荧光ARMS-PCR技术构建的检测方法,具有简便、高效、精确的特点,能够有效识别KRAS基因突变.此外,该方法在临床应用方面具有较高的参考价值,适用于推广使用.
Establishment of a method for detecting KRAS gene mutations based on Taqman fluorescent ARMS-PCR technology
Objective To establish a new method based on Taqman's fluorescent ARMS-PCR technique for detecting the KRAS mutations in human paraffin embedding tissue samples,which is a reference value of clinical medication.Methods Specific primers and probes were designed based on the conserved sequences of KRAS and internal reference genes(GAPDH).Taqman's fluorescent ARMS-PCR detection systems and sequencing systems were established for KRAS detection.In this paper,paraffin embedded tissue samples of 200 patients with colorectal cancer(CRC)are detected and compared with gold standard Sanger sequencing.The results of KRAS gene mutation are statistically analyzed,and the consistency of the two detection methods is analyzed.Results This method is able to detect KRAS gene mutations in human paraffin embedding tissue samples.And the results are 100%consistent with Sanger sequencing.Conclusion The method based on Taqman's fluorescent ARMS-PCR established in this research can detect KRAS mutations simply,quickly and accurately,which is valuable for clinical medication and suitable for clinical application.

ARMS-PCRKRASGene mutationSanger sequencing

林树洪、吴伟浩、万瑜、邓辉、吴湛彬

展开 >

511400 广州医科大学附属番禺中心医院消化科

ARMS-PCR KRAS 突变 Sanger测序

2024

现代消化及介入诊疗
广东省医学学术交流中心

现代消化及介入诊疗

CSTPCD
影响因子:1.019
ISSN:1672-2159
年,卷(期):2024.29(8)